#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=The biochemical and structural analyses of a new haloalkane dehalogenase DmxA from Antarctic bacterium Marinobacter sp .
2-1	14-17	The	abstract[2]	new[2]	_	_
2-2	18-29	biochemical	abstract[2]	new[2]	_	_
2-3	30-33	and	abstract[2]	new[2]	_	_
2-4	34-44	structural	abstract[2]	new[2]	_	_
2-5	45-53	analyses	abstract[2]	new[2]	_	_
2-6	54-56	of	abstract[2]	new[2]	_	_
2-7	57-58	a	abstract[2]|abstract[4]|object[5]	new[2]|new[4]|new[5]	coref	4-6[0_5]
2-8	59-62	new	abstract[2]|abstract[4]|object[5]	new[2]|new[4]|new[5]	_	_
2-9	63-73	haloalkane	abstract[2]|object|abstract[4]|object[5]	new[2]|new|new[4]|new[5]	_	_
2-10	74-86	dehalogenase	abstract[2]|abstract[4]|object[5]	new[2]|new[4]|new[5]	_	_
2-11	87-91	DmxA	abstract[2]|abstract[4]|object[5]	new[2]|new[4]|new[5]	_	_
2-12	92-96	from	abstract[2]|abstract[4]|object[5]	new[2]|new[4]|new[5]	_	_
2-13	97-106	Antarctic	abstract[2]|abstract[4]|object[5]|animal[8]	new[2]|new[4]|new[5]|new[8]	_	_
2-14	107-116	bacterium	abstract[2]|abstract[4]|object[5]|animal|animal[8]	new[2]|new[4]|new[5]|new|new[8]	_	_
2-15	117-129	Marinobacter	abstract[2]|abstract[4]|object[5]|person|animal[8]	new[2]|new[4]|new[5]|new|new[8]	_	_
2-16	130-132	sp	abstract[2]|abstract[4]|object[5]|animal[8]	new[2]|new[4]|new[5]|new[8]	_	_
2-17	133-134	.	_	_	_	_

#Text=ELB17 revealed the paradoxical stability of the enzyme .
3-1	135-140	ELB17	abstract	new	_	_
3-2	141-149	revealed	_	_	_	_
3-3	150-153	the	abstract[10]	new[10]	ana	4-2[0_10]
3-4	154-165	paradoxical	abstract[10]	new[10]	_	_
3-5	166-175	stability	abstract[10]	new[10]	_	_
3-6	176-178	of	abstract[10]	new[10]	_	_
3-7	179-182	the	abstract[10]|object[11]	new[10]|new[11]	coref	6-1[31_11]
3-8	183-189	enzyme	abstract[10]|object[11]	new[10]|new[11]	_	_
3-9	190-191	.	_	_	_	_

#Text=Despite its psychrophilic origin , DmxA wt exhibited the highest apparent melting temperature ( T m , app = 65.9 ± 0.1 °C ) of all biochemically characterized HLD-II members , and the second highest of all thus far characterized wild-type HLDs .
4-1	192-199	Despite	_	_	_	_
4-2	200-203	its	abstract|abstract[13]	giv|new[13]	coref|coref	9-13[54_13]|9-25[57_0]
4-3	204-217	psychrophilic	abstract[13]	new[13]	_	_
4-4	218-224	origin	abstract[13]	new[13]	_	_
4-5	225-226	,	_	_	_	_
4-6	227-231	DmxA	object|abstract[15]	giv|new[15]	coref|coref	5-10|10-9[70_15]
4-7	232-234	wt	abstract[15]	new[15]	_	_
4-8	235-244	exhibited	_	_	_	_
4-9	245-248	the	abstract[17]	new[17]	coref	5-5[28_17]
4-10	249-256	highest	abstract[17]	new[17]	_	_
4-11	257-265	apparent	abstract[17]	new[17]	_	_
4-12	266-273	melting	object|abstract[17]	new|new[17]	coref	5-7
4-13	274-285	temperature	abstract[17]	new[17]	_	_
4-14	286-287	(	_	_	_	_
4-15	288-289	T	person[18]	new[18]	coref	6-12[35_18]
4-16	290-291	m	person[18]|quantity	new[18]|new	_	_
4-17	292-293	,	_	_	_	_
4-18	294-297	app	quantity	new	coref	6-15
4-19	298-299	=	_	_	_	_
4-20	300-304	65.9	quantity	new	_	_
4-21	305-306	±	_	_	_	_
4-22	307-310	0.1	quantity[22]	new[22]	_	_
4-23	311-313	°C	quantity[22]	new[22]	_	_
4-24	314-315	)	_	_	_	_
4-25	316-318	of	_	_	_	_
4-26	319-322	all	_	_	_	_
4-27	323-336	biochemically	_	_	_	_
4-28	337-350	characterized	_	_	_	_
4-29	351-357	HLD-II	event|person[24]	new|new[24]	coref|coref	18-29[137_24]|18-34
4-30	358-365	members	person[24]	new[24]	_	_
4-31	366-367	,	_	_	_	_
4-32	368-371	and	_	_	_	_
4-33	372-375	the	_	_	_	_
4-34	376-382	second	_	_	_	_
4-35	383-390	highest	_	_	_	_
4-36	391-393	of	_	_	_	_
4-37	394-397	all	_	_	_	_
4-38	398-402	thus	_	_	_	_
4-39	403-406	far	_	_	_	_
4-40	407-420	characterized	_	_	_	_
4-41	421-430	wild-type	substance[25]	new[25]	coref	24-8[0_25]
4-42	431-435	HLDs	substance[25]	new[25]	_	_
4-43	436-437	.	_	_	_	_

#Text=The only HLD exhibiting higher apparent melting temperature than DmxA was DhmeA from halophilic archaea Haloferax mediterranei ATCC 33500 , which belongs to the subfamily HLD-III .
5-1	438-441	The	object[26]	new[26]	coref	12-8[0_26]
5-2	442-446	only	object[26]	new[26]	_	_
5-3	447-450	HLD	object[26]	new[26]	_	_
5-4	451-461	exhibiting	_	_	_	_
5-5	462-468	higher	abstract[28]	giv[28]	coref	22-8[165_28]
5-6	469-477	apparent	abstract[28]	giv[28]	_	_
5-7	478-485	melting	object|abstract[28]	giv|giv[28]	coref	22-9
5-8	486-497	temperature	abstract[28]	giv[28]	_	_
5-9	498-502	than	abstract[28]	giv[28]	_	_
5-10	503-507	DmxA	abstract[28]|object	giv[28]|giv	coref	7-18
5-11	508-511	was	_	_	_	_
5-12	512-517	DhmeA	_	_	_	_
5-13	518-522	from	_	_	_	_
5-14	523-533	halophilic	_	_	_	_
5-15	534-541	archaea	_	_	_	_
5-16	542-551	Haloferax	_	_	_	_
5-17	552-564	mediterranei	_	_	_	_
5-18	565-569	ATCC	_	_	_	_
5-19	570-575	33500	_	_	_	_
5-20	576-577	,	_	_	_	_
5-21	578-583	which	_	_	_	_
5-22	584-591	belongs	_	_	_	_
5-23	592-594	to	_	_	_	_
5-24	595-598	the	abstract[30]	new[30]	coref	6-5[33_30]
5-25	599-608	subfamily	abstract[30]	new[30]	_	_
5-26	609-616	HLD-III	abstract[30]	new[30]	_	_
5-27	617-618	.	_	_	_	_

#Text=The enzyme DhmeA from subfamily HLD-III is a multimeric protein with T m , app = 70.6 °C .
6-1	619-622	The	substance[31]|substance[32]	giv[31]|new[32]	coref|coref	6-8[34_32]|14-35[105_31]
6-2	623-629	enzyme	substance[31]|substance[32]	giv[31]|new[32]	_	_
6-3	630-635	DhmeA	substance[32]	new[32]	_	_
6-4	636-640	from	substance[32]	new[32]	_	_
6-5	641-650	subfamily	substance[32]|abstract[33]	new[32]|giv[33]	coref	18-32[138_33]
6-6	651-658	HLD-III	substance[32]|abstract[33]	new[32]|giv[33]	_	_
6-7	659-661	is	_	_	_	_
6-8	662-663	a	substance[34]	giv[34]	coref	7-5[0_34]
6-9	664-674	multimeric	substance[34]	giv[34]	_	_
6-10	675-682	protein	substance[34]	giv[34]	_	_
6-11	683-687	with	substance[34]	giv[34]	_	_
6-12	688-689	T	substance[34]|quantity[35]	giv[34]|giv[35]	coref	22-19[0_35]
6-13	690-691	m	substance[34]|quantity[35]	giv[34]|giv[35]	_	_
6-14	692-693	,	_	_	_	_
6-15	694-697	app	abstract	giv	coref	22-22
6-16	698-699	=	_	_	_	_
6-17	700-704	70.6	quantity[37]	new[37]	_	_
6-18	705-707	°C	quantity[37]	new[37]	_	_
6-19	708-709	.	_	_	_	_

#Text=The tertiary structure of DhmeA is not available at this moment , preventing its direct comparison with DmxA .
7-1	710-713	The	abstract[38]	new[38]	coref	9-34[59_38]
7-2	714-722	tertiary	abstract[38]	new[38]	_	_
7-3	723-732	structure	abstract[38]	new[38]	_	_
7-4	733-735	of	abstract[38]	new[38]	_	_
7-5	736-741	DhmeA	abstract[38]|substance	new[38]|giv	ana	7-14
7-6	742-744	is	_	_	_	_
7-7	745-748	not	_	_	_	_
7-8	749-758	available	_	_	_	_
7-9	759-761	at	_	_	_	_
7-10	762-766	this	time[40]	new[40]	_	_
7-11	767-773	moment	time[40]	new[40]	_	_
7-12	774-775	,	_	_	_	_
7-13	776-786	preventing	_	_	_	_
7-14	787-790	its	substance|abstract[42]	giv|new[42]	coref	14-4
7-15	791-797	direct	abstract[42]	new[42]	_	_
7-16	798-808	comparison	abstract[42]	new[42]	_	_
7-17	809-813	with	abstract[42]	new[42]	_	_
7-18	814-818	DmxA	abstract[42]|abstract	new[42]|giv	coref	10-9
7-19	819-820	.	_	_	_	_

#Text=Several thermostable enzymes from psychrophiles and mesophiles have been reported in the literature ; however , their unexpected thermostability remains poorly understood .
8-1	821-828	Several	abstract[44]	new[44]	coref	9-6[51_44]
8-2	829-841	thermostable	abstract[44]	new[44]	_	_
8-3	842-849	enzymes	abstract[44]	new[44]	_	_
8-4	850-854	from	abstract[44]	new[44]	_	_
8-5	855-868	psychrophiles	abstract[44]|substance	new[44]|new	_	_
8-6	869-872	and	abstract[44]	new[44]	_	_
8-7	873-883	mesophiles	abstract[44]|substance	new[44]|new	ana	8-17
8-8	884-888	have	_	_	_	_
8-9	889-893	been	_	_	_	_
8-10	894-902	reported	_	_	_	_
8-11	903-905	in	_	_	_	_
8-12	906-909	the	abstract[47]	new[47]	_	_
8-13	910-920	literature	abstract[47]	new[47]	_	_
8-14	921-922	;	_	_	_	_
8-15	923-930	however	_	_	_	_
8-16	931-932	,	_	_	_	_
8-17	933-938	their	substance|abstract[49]	giv|new[49]	_	_
8-18	939-949	unexpected	abstract[49]	new[49]	_	_
8-19	950-965	thermostability	abstract[49]	new[49]	_	_
8-20	966-973	remains	_	_	_	_
8-21	974-980	poorly	_	_	_	_
8-22	981-991	understood	_	_	_	_
8-23	992-993	.	_	_	_	_

#Text=Only two studies focused on such paradoxically thermostable enzymes from psychrophilic and mesophilic origin have attempted so far to explain the structural basis of their stability , suggesting that either the flexibility of a global structure or the presence of extra disulfide and salt bridges are responsible for the unusual thermal stability of these enzymes .
9-1	994-998	Only	abstract[50]	new[50]	_	_
9-2	999-1002	two	abstract[50]	new[50]	_	_
9-3	1003-1010	studies	abstract[50]	new[50]	_	_
9-4	1011-1018	focused	_	_	_	_
9-5	1019-1021	on	_	_	_	_
9-6	1022-1026	such	abstract[51]	giv[51]	ana	9-25[0_51]
9-7	1027-1040	paradoxically	abstract[51]	giv[51]	_	_
9-8	1041-1053	thermostable	abstract[51]	giv[51]	_	_
9-9	1054-1061	enzymes	abstract[51]	giv[51]	_	_
9-10	1062-1066	from	abstract[51]	giv[51]	_	_
9-11	1067-1080	psychrophilic	abstract[51]|person	giv[51]|new	_	_
9-12	1081-1084	and	abstract[51]	giv[51]	_	_
9-13	1085-1095	mesophilic	abstract[51]|place|abstract[54]	giv[51]|new|giv[54]	_	_
9-14	1096-1102	origin	abstract[51]|abstract[54]	giv[51]|giv[54]	_	_
9-15	1103-1107	have	_	_	_	_
9-16	1108-1117	attempted	_	_	_	_
9-17	1118-1120	so	_	_	_	_
9-18	1121-1124	far	_	_	_	_
9-19	1125-1127	to	_	_	_	_
9-20	1128-1135	explain	_	_	_	_
9-21	1136-1139	the	abstract[55]	new[55]	_	_
9-22	1140-1150	structural	abstract[55]	new[55]	_	_
9-23	1151-1156	basis	abstract[55]	new[55]	_	_
9-24	1157-1159	of	abstract[55]	new[55]	_	_
9-25	1160-1165	their	abstract[55]|abstract|abstract[57]	new[55]|giv|giv[57]	coref	9-54[66_0]
9-26	1166-1175	stability	abstract[55]|abstract[57]	new[55]|giv[57]	_	_
9-27	1176-1177	,	_	_	_	_
9-28	1178-1188	suggesting	_	_	_	_
9-29	1189-1193	that	_	_	_	_
9-30	1194-1200	either	abstract[58]	new[58]	_	_
9-31	1201-1204	the	abstract[58]	new[58]	_	_
9-32	1205-1216	flexibility	abstract[58]	new[58]	_	_
9-33	1217-1219	of	abstract[58]	new[58]	_	_
9-34	1220-1221	a	abstract[58]|abstract[59]	new[58]|giv[59]	ana	10-17[0_59]
9-35	1222-1228	global	abstract[58]|abstract[59]	new[58]|giv[59]	_	_
9-36	1229-1238	structure	abstract[58]|abstract[59]	new[58]|giv[59]	_	_
9-37	1239-1241	or	_	_	_	_
9-38	1242-1245	the	abstract[60]	new[60]	coref	15-7[108_60]
9-39	1246-1254	presence	abstract[60]	new[60]	_	_
9-40	1255-1257	of	abstract[60]	new[60]	_	_
9-41	1258-1263	extra	abstract[60]|substance[61]	new[60]|new[61]	coref	17-4[0_61]
9-42	1264-1273	disulfide	abstract[60]|substance[61]	new[60]|new[61]	_	_
9-43	1274-1277	and	abstract[60]	new[60]	_	_
9-44	1278-1282	salt	abstract[60]|substance|object[63]	new[60]|new|new[63]	_	_
9-45	1283-1290	bridges	abstract[60]|object[63]	new[60]|new[63]	_	_
9-46	1291-1294	are	_	_	_	_
9-47	1295-1306	responsible	_	_	_	_
9-48	1307-1310	for	_	_	_	_
9-49	1311-1314	the	abstract[65]	new[65]	coref	10-17[72_65]
9-50	1315-1322	unusual	abstract[65]	new[65]	_	_
9-51	1323-1330	thermal	animal|abstract[65]	new|new[65]	_	_
9-52	1331-1340	stability	abstract[65]	new[65]	_	_
9-53	1341-1343	of	abstract[65]	new[65]	_	_
9-54	1344-1349	these	abstract[65]|abstract[66]	new[65]|giv[66]	_	_
9-55	1350-1357	enzymes	abstract[65]|abstract[66]	new[65]|giv[66]	_	_
9-56	1358-1359	.	_	_	_	_

#Text=In this study , several structural features of DmxA wt were analyzed in detail to explain its extraordinary stability .
10-1	1360-1362	In	_	_	_	_
10-2	1363-1367	this	abstract[67]	new[67]	_	_
10-3	1368-1373	study	abstract[67]	new[67]	_	_
10-4	1374-1375	,	_	_	_	_
10-5	1376-1383	several	abstract[68]	new[68]	_	_
10-6	1384-1394	structural	abstract[68]	new[68]	_	_
10-7	1395-1403	features	abstract[68]	new[68]	_	_
10-8	1404-1406	of	abstract[68]	new[68]	_	_
10-9	1407-1411	DmxA	abstract[68]|abstract|abstract[70]	new[68]|giv|giv[70]	coref|coref	11-1[73_70]|14-16
10-10	1412-1414	wt	abstract[68]|abstract[70]	new[68]|giv[70]	_	_
10-11	1415-1419	were	_	_	_	_
10-12	1420-1428	analyzed	_	_	_	_
10-13	1429-1431	in	_	_	_	_
10-14	1432-1438	detail	_	_	_	_
10-15	1439-1441	to	_	_	_	_
10-16	1442-1449	explain	_	_	_	_
10-17	1450-1453	its	abstract|abstract[72]	giv|giv[72]	coref|coref	14-29[102_72]|18-16[134_0]
10-18	1454-1467	extraordinary	abstract[72]	giv[72]	_	_
10-19	1468-1477	stability	abstract[72]	giv[72]	_	_
10-20	1478-1479	.	_	_	_	_

#Text=DmxA wt was found to form a dimer via a cysteine bridge , which may be formed only after heterologous expression in E. coli and purification , while is less likely to occur in the cytoplasm of the original host organism .
11-1	1480-1484	DmxA	abstract[73]	giv[73]	coref	14-17[0_73]
11-2	1485-1487	wt	abstract[73]	giv[73]	_	_
11-3	1488-1491	was	_	_	_	_
11-4	1492-1497	found	_	_	_	_
11-5	1498-1500	to	_	_	_	_
11-6	1501-1505	form	abstract	new	coref|none	14-20[100_0]|11-6[0_100]
11-7	1506-1507	a	object[74]	new[74]	_	_
11-8	1508-1513	dimer	object[74]	new[74]	_	_
11-9	1514-1517	via	object[74]	new[74]	_	_
11-10	1518-1519	a	object[74]|object[76]	new[74]|new[76]	coref	14-12[96_76]
11-11	1520-1528	cysteine	object[74]|place|object[76]	new[74]|new|new[76]	coref	15-13
11-12	1529-1535	bridge	object[74]|object[76]	new[74]|new[76]	_	_
11-13	1536-1537	,	_	_	_	_
11-14	1538-1543	which	_	_	_	_
11-15	1544-1547	may	_	_	_	_
11-16	1548-1550	be	_	_	_	_
11-17	1551-1557	formed	_	_	_	_
11-18	1558-1562	only	abstract[78]	new[78]	ana	12-1[0_78]
11-19	1563-1568	after	abstract[78]	new[78]	_	_
11-20	1569-1581	heterologous	person|abstract[78]	new|new[78]	_	_
11-21	1582-1592	expression	abstract[78]	new[78]	_	_
11-22	1593-1595	in	abstract[78]	new[78]	_	_
11-23	1596-1598	E.	abstract[78]	new[78]	_	_
11-24	1599-1603	coli	abstract[78]	new[78]	_	_
11-25	1604-1607	and	abstract[78]	new[78]	_	_
11-26	1608-1620	purification	abstract[78]|substance	new[78]|new	_	_
11-27	1621-1622	,	_	_	_	_
11-28	1623-1628	while	_	_	_	_
11-29	1629-1631	is	_	_	_	_
11-30	1632-1636	less	_	_	_	_
11-31	1637-1643	likely	_	_	_	_
11-32	1644-1646	to	_	_	_	_
11-33	1647-1652	occur	_	_	_	_
11-34	1653-1655	in	_	_	_	_
11-35	1656-1659	the	place[80]	new[80]	_	_
11-36	1660-1669	cytoplasm	place[80]	new[80]	_	_
11-37	1670-1672	of	place[80]	new[80]	_	_
11-38	1673-1676	the	place[80]|animal[81]	new[80]|new[81]	_	_
11-39	1677-1685	original	place[80]|animal[81]	new[80]|new[81]	_	_
11-40	1686-1690	host	place[80]|animal[81]	new[80]|new[81]	_	_
11-41	1691-1699	organism	place[80]|animal[81]	new[80]|new[81]	_	_
11-42	1700-1701	.	_	_	_	_

#Text=This is the first observation ever of HLD oligomerization mediated by the covalent bond .
12-1	1702-1706	This	abstract	giv	coref	12-3[83_0]
12-2	1707-1709	is	_	_	_	_
12-3	1710-1713	the	abstract[83]	giv[83]	_	_
12-4	1714-1719	first	abstract[83]	giv[83]	_	_
12-5	1720-1731	observation	abstract[83]	giv[83]	_	_
12-6	1732-1736	ever	abstract[83]	giv[83]	_	_
12-7	1737-1739	of	abstract[83]	giv[83]	_	_
12-8	1740-1743	HLD	abstract[83]|object|object[85]	giv[83]|giv|new[85]	coref	19-1[140_0]
12-9	1744-1759	oligomerization	abstract[83]|object[85]	giv[83]|new[85]	_	_
12-10	1760-1768	mediated	_	_	_	_
12-11	1769-1771	by	_	_	_	_
12-12	1772-1775	the	abstract[86]	new[86]	_	_
12-13	1776-1784	covalent	abstract[86]	new[86]	_	_
12-14	1785-1789	bond	abstract[86]	new[86]	_	_
12-15	1790-1791	.	_	_	_	_

#Text=Thus far , the reported dimers of DbjA and DbeA were formed through the hydrophobic interactions of C-terminal α-helices .
13-1	1792-1796	Thus	_	_	_	_
13-2	1797-1800	far	_	_	_	_
13-3	1801-1802	,	_	_	_	_
13-4	1803-1806	the	object[87]	new[87]	_	_
13-5	1807-1815	reported	object[87]	new[87]	_	_
13-6	1816-1822	dimers	object[87]	new[87]	_	_
13-7	1823-1825	of	object[87]	new[87]	_	_
13-8	1826-1830	DbjA	object[87]|abstract	new[87]|new	_	_
13-9	1831-1834	and	object[87]	new[87]	_	_
13-10	1835-1839	DbeA	object[87]|abstract	new[87]|new	_	_
13-11	1840-1844	were	_	_	_	_
13-12	1845-1851	formed	_	_	_	_
13-13	1852-1859	through	_	_	_	_
13-14	1860-1863	the	abstract[90]	new[90]	coref	22-35[175_90]
13-15	1864-1875	hydrophobic	abstract[90]	new[90]	_	_
13-16	1876-1888	interactions	abstract[90]	new[90]	_	_
13-17	1889-1891	of	abstract[90]	new[90]	_	_
13-18	1892-1902	C-terminal	abstract[90]|object[91]	new[90]|new[91]	_	_
13-19	1903-1912	α-helices	abstract[90]|object[91]	new[90]|new[91]	_	_
13-20	1913-1914	.	_	_	_	_

#Text=Although cysteines in protein structures often serve as stabilizing elements , the S-S bridge between DmxA wt units in its dimeric form did not have any effect on the stability or the activity of the enzyme .
14-1	1915-1923	Although	_	_	_	_
14-2	1924-1933	cysteines	substance[92]	new[92]	_	_
14-3	1934-1936	in	substance[92]	new[92]	_	_
14-4	1937-1944	protein	substance[92]|substance|abstract[94]	new[92]|giv|new[94]	coref|coref	22-39|27-20[216_94]
14-5	1945-1955	structures	substance[92]|abstract[94]	new[92]|new[94]	_	_
14-6	1956-1961	often	_	_	_	_
14-7	1962-1967	serve	_	_	_	_
14-8	1968-1970	as	_	_	_	_
14-9	1971-1982	stabilizing	_	_	_	_
14-10	1983-1991	elements	_	_	_	_
14-11	1992-1993	,	_	_	_	_
14-12	1994-1997	the	object[96]	giv[96]	coref	15-12[111_96]
14-13	1998-2001	S-S	place|object[96]	new|giv[96]	_	_
14-14	2002-2008	bridge	object[96]	giv[96]	_	_
14-15	2009-2016	between	object[96]	giv[96]	_	_
14-16	2017-2021	DmxA	object[96]|event|organization[99]	giv[96]|giv|new[99]	coref	16-8
14-17	2022-2024	wt	object[96]|abstract|organization[99]	giv[96]|giv|new[99]	coref	16-8[118_0]
14-18	2025-2030	units	object[96]|organization[99]	giv[96]|new[99]	_	_
14-19	2031-2033	in	object[96]|organization[99]	giv[96]|new[99]	_	_
14-20	2034-2037	its	object[96]|organization[99]|abstract[100]	giv[96]|new[99]|new[100]	_	_
14-21	2038-2045	dimeric	object[96]|organization[99]|abstract[100]	giv[96]|new[99]|new[100]	_	_
14-22	2046-2050	form	object[96]|organization[99]|abstract[100]	giv[96]|new[99]|new[100]	_	_
14-23	2051-2054	did	_	_	_	_
14-24	2055-2058	not	_	_	_	_
14-25	2059-2063	have	_	_	_	_
14-26	2064-2067	any	abstract[101]	new[101]	coref	22-30[173_101]
14-27	2068-2074	effect	abstract[101]	new[101]	_	_
14-28	2075-2077	on	abstract[101]	new[101]	_	_
14-29	2078-2081	the	abstract[101]|abstract[102]|abstract[103]	new[101]|giv[102]|new[103]	coref	20-11[150_103]
14-30	2082-2091	stability	abstract[101]|abstract[102]|abstract[103]	new[101]|giv[102]|new[103]	_	_
14-31	2092-2094	or	abstract[101]|abstract[103]	new[101]|new[103]	_	_
14-32	2095-2098	the	abstract[101]|abstract[103]|abstract[104]	new[101]|new[103]|new[104]	coref	32-53[277_104]
14-33	2099-2107	activity	abstract[101]|abstract[103]|abstract[104]	new[101]|new[103]|new[104]	_	_
14-34	2108-2110	of	abstract[101]|abstract[103]|abstract[104]	new[101]|new[103]|new[104]	_	_
14-35	2111-2114	the	abstract[101]|abstract[103]|abstract[104]|substance[105]	new[101]|new[103]|new[104]|giv[105]	coref	15-27[115_105]
14-36	2115-2121	enzyme	abstract[101]|abstract[103]|abstract[104]|substance[105]	new[101]|new[103]|new[104]|giv[105]	_	_
14-37	2122-2123	.	_	_	_	_

#Text=Furthermore , our experiments revealed that the presence or absence of such cysteine bridge neither influenced any of the catalytic properties nor the storage stability of the enzyme .
15-1	2124-2135	Furthermore	_	_	_	_
15-2	2136-2137	,	_	_	_	_
15-3	2138-2141	our	person|abstract[107]	acc|new[107]	ana	25-2
15-4	2142-2153	experiments	abstract[107]	new[107]	_	_
15-5	2154-2162	revealed	_	_	_	_
15-6	2163-2167	that	_	_	_	_
15-7	2168-2171	the	abstract[108]	giv[108]	_	_
15-8	2172-2180	presence	abstract[108]	giv[108]	_	_
15-9	2181-2183	or	_	_	_	_
15-10	2184-2191	absence	abstract[109]	new[109]	_	_
15-11	2192-2194	of	abstract[109]	new[109]	_	_
15-12	2195-2199	such	abstract[109]|object[111]	new[109]|giv[111]	coref	17-3[125_111]
15-13	2200-2208	cysteine	abstract[109]|place|object[111]	new[109]|giv|giv[111]	_	_
15-14	2209-2215	bridge	abstract[109]|object[111]	new[109]|giv[111]	_	_
15-15	2216-2223	neither	_	_	_	_
15-16	2224-2234	influenced	_	_	_	_
15-17	2235-2238	any	_	_	_	_
15-18	2239-2241	of	_	_	_	_
15-19	2242-2245	the	abstract[112]	new[112]	_	_
15-20	2246-2255	catalytic	abstract[112]	new[112]	_	_
15-21	2256-2266	properties	abstract[112]	new[112]	_	_
15-22	2267-2270	nor	_	_	_	_
15-23	2271-2274	the	abstract[114]	new[114]	ana	16-1[0_114]
15-24	2275-2282	storage	place|abstract[114]	new|new[114]	_	_
15-25	2283-2292	stability	abstract[114]	new[114]	_	_
15-26	2293-2295	of	abstract[114]	new[114]	_	_
15-27	2296-2299	the	abstract[114]|substance[115]	new[114]|giv[115]	coref	16-22[122_115]
15-28	2300-2306	enzyme	abstract[114]|substance[115]	new[114]|giv[115]	_	_
15-29	2307-2308	.	_	_	_	_

#Text=It is also worth mentioning that the DmxA wt oligomer equilibrium varies in solution , and only a small part of the enzyme ( up to 30 % ) is present as a dimer .
16-1	2309-2311	It	abstract	giv	_	_
16-2	2312-2314	is	_	_	_	_
16-3	2315-2319	also	_	_	_	_
16-4	2320-2325	worth	_	_	_	_
16-5	2326-2336	mentioning	_	_	_	_
16-6	2337-2341	that	_	_	_	_
16-7	2342-2345	the	abstract[120]	new[120]	_	_
16-8	2346-2350	DmxA	abstract|abstract[118]|abstract[120]	giv|giv[118]|new[120]	coref|coref	18-12|18-13[0_118]
16-9	2351-2353	wt	abstract[118]|abstract[120]	giv[118]|new[120]	_	_
16-10	2354-2362	oligomer	person|abstract[120]	new|new[120]	_	_
16-11	2363-2374	equilibrium	abstract[120]	new[120]	_	_
16-12	2375-2381	varies	_	_	_	_
16-13	2382-2384	in	_	_	_	_
16-14	2385-2393	solution	substance	new	_	_
16-15	2394-2395	,	_	_	_	_
16-16	2396-2399	and	_	_	_	_
16-17	2400-2404	only	_	_	_	_
16-18	2405-2406	a	_	_	_	_
16-19	2407-2412	small	_	_	_	_
16-20	2413-2417	part	_	_	_	_
16-21	2418-2420	of	_	_	_	_
16-22	2421-2424	the	substance[122]	giv[122]	coref	17-14[127_122]
16-23	2425-2431	enzyme	substance[122]	giv[122]	_	_
16-24	2432-2433	(	_	_	_	_
16-25	2434-2436	up	_	_	_	_
16-26	2437-2439	to	_	_	_	_
16-27	2440-2442	30	quantity[123]	new[123]	_	_
16-28	2443-2444	%	quantity[123]	new[123]	_	_
16-29	2445-2446	)	_	_	_	_
16-30	2447-2449	is	_	_	_	_
16-31	2450-2457	present	_	_	_	_
16-32	2458-2460	as	_	_	_	_
16-33	2461-2462	a	_	_	_	_
16-34	2463-2468	dimer	_	_	_	_
16-35	2469-2470	.	_	_	_	_

#Text=Therefore , the disulfide bridge does not contribute to the overall stability of the enzyme .
17-1	2471-2480	Therefore	_	_	_	_
17-2	2481-2482	,	_	_	_	_
17-3	2483-2486	the	object[125]	giv[125]	_	_
17-4	2487-2496	disulfide	substance|object[125]	giv|giv[125]	_	_
17-5	2497-2503	bridge	object[125]	giv[125]	_	_
17-6	2504-2508	does	_	_	_	_
17-7	2509-2512	not	_	_	_	_
17-8	2513-2523	contribute	_	_	_	_
17-9	2524-2526	to	_	_	_	_
17-10	2527-2530	the	abstract[126]	new[126]	ana	18-10[130_126]
17-11	2531-2538	overall	abstract[126]	new[126]	_	_
17-12	2539-2548	stability	abstract[126]	new[126]	_	_
17-13	2549-2551	of	abstract[126]	new[126]	_	_
17-14	2552-2555	the	abstract[126]|substance[127]	new[126]|giv[127]	coref	20-11[0_127]
17-15	2556-2562	enzyme	abstract[126]|substance[127]	new[126]|giv[127]	_	_
17-16	2563-2564	.	_	_	_	_

#Text=A unique composition of the catalytic pentad was observed both in DmxA wt sequence and crystal structure , containing a glutamine instead of the typical asparagine present in other members of the subfamily HLD-II .
18-1	2565-2566	A	abstract[128]	new[128]	_	_
18-2	2567-2573	unique	abstract[128]	new[128]	_	_
18-3	2574-2585	composition	abstract[128]	new[128]	_	_
18-4	2586-2588	of	abstract[128]	new[128]	_	_
18-5	2589-2592	the	abstract[128]|object[129]	new[128]|new[129]	_	_
18-6	2593-2602	catalytic	abstract[128]|object[129]	new[128]|new[129]	_	_
18-7	2603-2609	pentad	abstract[128]|object[129]	new[128]|new[129]	_	_
18-8	2610-2613	was	_	_	_	_
18-9	2614-2622	observed	_	_	_	_
18-10	2623-2627	both	abstract[130]	giv[130]	coref	20-11[149_130]
18-11	2628-2630	in	abstract[130]	giv[130]	_	_
18-12	2631-2635	DmxA	abstract[130]|abstract|abstract[133]	giv[130]|giv|new[133]	coref	21-9
18-13	2636-2638	wt	abstract[130]|abstract|abstract[133]	giv[130]|giv|new[133]	coref	21-10
18-14	2639-2647	sequence	abstract[130]|abstract[133]	giv[130]|new[133]	_	_
18-15	2648-2651	and	abstract[130]	giv[130]	_	_
18-16	2652-2659	crystal	abstract[130]|abstract[134]	giv[130]|giv[134]	coref	21-9[159_134]
18-17	2660-2669	structure	abstract[130]|abstract[134]	giv[130]|giv[134]	_	_
18-18	2670-2671	,	_	_	_	_
18-19	2672-2682	containing	_	_	_	_
18-20	2683-2684	a	substance[135]	new[135]	coref	22-3[162_135]
18-21	2685-2694	glutamine	substance[135]	new[135]	_	_
18-22	2695-2702	instead	substance[135]	new[135]	_	_
18-23	2703-2705	of	substance[135]	new[135]	_	_
18-24	2706-2709	the	substance[135]	new[135]	_	_
18-25	2710-2717	typical	substance[135]	new[135]	_	_
18-26	2718-2728	asparagine	substance[135]|substance	new[135]|new	coref	22-6
18-27	2729-2736	present	substance[135]	new[135]	_	_
18-28	2737-2739	in	substance[135]	new[135]	_	_
18-29	2740-2745	other	substance[135]|person[137]	new[135]|giv[137]	_	_
18-30	2746-2753	members	substance[135]|person[137]	new[135]|giv[137]	_	_
18-31	2754-2756	of	substance[135]|person[137]	new[135]|giv[137]	_	_
18-32	2757-2760	the	substance[135]|person[137]|abstract[138]	new[135]|giv[137]|giv[138]	_	_
18-33	2761-2770	subfamily	substance[135]|person[137]|abstract[138]	new[135]|giv[137]|giv[138]	_	_
18-34	2771-2777	HLD-II	substance[135]|person[137]|abstract[138]|event	new[135]|giv[137]|giv[138]|giv	_	_
18-35	2778-2779	.	_	_	_	_

#Text=Another HLD with an unusual halide-stabilizing residue ( DatA containing tyrosine instead of tryptophan ) was described earlier .
19-1	2780-2787	Another	object[140]	giv[140]	_	_
19-2	2788-2791	HLD	object[140]	giv[140]	_	_
19-3	2792-2796	with	object[140]	giv[140]	_	_
19-4	2797-2799	an	object[140]|object[141]	giv[140]|new[141]	appos	19-9[0_141]
19-5	2800-2807	unusual	object[140]|object[141]	giv[140]|new[141]	_	_
19-6	2808-2826	halide-stabilizing	object[140]|object[141]	giv[140]|new[141]	_	_
19-7	2827-2834	residue	object[140]|object[141]	giv[140]|new[141]	_	_
19-8	2835-2836	(	_	_	_	_
19-9	2837-2841	DatA	object	giv	coref	20-5[147_0]
19-10	2842-2852	containing	_	_	_	_
19-11	2853-2861	tyrosine	substance	new	_	_
19-12	2862-2869	instead	_	_	_	_
19-13	2870-2872	of	_	_	_	_
19-14	2873-2883	tryptophan	substance	new	_	_
19-15	2884-2885	)	_	_	_	_
19-16	2886-2889	was	_	_	_	_
19-17	2890-2899	described	_	_	_	_
19-18	2900-2907	earlier	_	_	_	_
19-19	2908-2909	.	_	_	_	_

#Text=In this case , the unique halide stabilizing residue decreased enzyme stability ( by 3.5 °C ) and only moderately affected enzyme specificity .
20-1	2910-2912	In	_	_	_	_
20-2	2913-2917	this	abstract[145]	new[145]	coref	25-2[193_145]
20-3	2918-2922	case	abstract[145]	new[145]	_	_
20-4	2923-2924	,	_	_	_	_
20-5	2925-2928	the	object[147]	giv[147]	_	_
20-6	2929-2935	unique	object[147]	giv[147]	_	_
20-7	2936-2942	halide	substance|object[147]	new|giv[147]	_	_
20-8	2943-2954	stabilizing	object[147]	giv[147]	_	_
20-9	2955-2962	residue	object[147]	giv[147]	_	_
20-10	2963-2972	decreased	_	_	_	_
20-11	2973-2979	enzyme	object|abstract[149]|abstract[150]	giv|giv[149]|giv[150]	coref|coref	20-22|32-50[276_150]
20-12	2980-2989	stability	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
20-13	2990-2991	(	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
20-14	2992-2994	by	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
20-15	2995-2998	3.5	abstract[149]|abstract[150]|quantity[151]	giv[149]|giv[150]|new[151]	_	_
20-16	2999-3001	°C	abstract[149]|abstract[150]|quantity[151]	giv[149]|giv[150]|new[151]	_	_
20-17	3002-3003	)	abstract[149]|abstract[150]	giv[149]|giv[150]	_	_
20-18	3004-3007	and	abstract[150]	giv[150]	_	_
20-19	3008-3012	only	abstract[150]	giv[150]	_	_
20-20	3013-3023	moderately	abstract[150]	giv[150]	_	_
20-21	3024-3032	affected	abstract[150]	giv[150]	_	_
20-22	3033-3039	enzyme	abstract[150]|object|abstract[153]	giv[150]|giv|new[153]	coref|coref	22-12[166_0]|23-7[180_153]
20-23	3040-3051	specificity	abstract[150]|abstract[153]	giv[150]|new[153]	_	_
20-24	3052-3053	.	_	_	_	_

#Text=The position of the Q40 side chain in DmxA wt structure disables its functioning as a halide-stabilizing residue .
21-1	3054-3057	The	abstract[154]	new[154]	_	_
21-2	3058-3066	position	abstract[154]	new[154]	_	_
21-3	3067-3069	of	abstract[154]	new[154]	_	_
21-4	3070-3073	the	abstract[154]|object[156]	new[154]|new[156]	_	_
21-5	3074-3077	Q40	abstract[154]|place|object[156]	new[154]|new|new[156]	_	_
21-6	3078-3082	side	abstract[154]|object[156]	new[154]|new[156]	_	_
21-7	3083-3088	chain	abstract[154]|object[156]	new[154]|new[156]	_	_
21-8	3089-3091	in	abstract[154]|object[156]	new[154]|new[156]	_	_
21-9	3092-3096	DmxA	abstract[154]|object[156]|object|abstract[159]	new[154]|new[156]|giv|giv[159]	ana|coref	21-13[0_159]|23-16[184_0]
21-10	3097-3099	wt	abstract[154]|object[156]|abstract|abstract[159]	new[154]|new[156]|giv|giv[159]	coref	26-6
21-11	3100-3109	structure	abstract[154]|object[156]|abstract[159]	new[154]|new[156]|giv[159]	_	_
21-12	3110-3118	disables	_	_	_	_
21-13	3119-3122	its	abstract|abstract[161]	giv|new[161]	coref	26-5[202_0]
21-14	3123-3134	functioning	abstract[161]	new[161]	_	_
21-15	3135-3137	as	_	_	_	_
21-16	3138-3139	a	_	_	_	_
21-17	3140-3158	halide-stabilizing	_	_	_	_
21-18	3159-3166	residue	_	_	_	_
21-19	3167-3168	.	_	_	_	_

#Text=When replacing the glutamine with asparagine , the melting temperature of the enzyme decreased by 2 °C ( T m , app = 63.9 ± 0.2 °C ) confirming a small stabilizing effect of glutamine interactions in the protein core .
22-1	3169-3173	When	_	_	_	_
22-2	3174-3183	replacing	_	_	_	_
22-3	3184-3187	the	substance[162]	giv[162]	coref	22-35[0_162]
22-4	3188-3197	glutamine	substance[162]	giv[162]	_	_
22-5	3198-3202	with	substance[162]	giv[162]	_	_
22-6	3203-3213	asparagine	substance[162]|substance	giv[162]|giv	coref	32-37
22-7	3214-3215	,	_	_	_	_
22-8	3216-3219	the	abstract[165]	giv[165]	coref	29-16[237_165]
22-9	3220-3227	melting	object|abstract[165]	giv|giv[165]	coref	29-19
22-10	3228-3239	temperature	abstract[165]	giv[165]	_	_
22-11	3240-3242	of	abstract[165]	giv[165]	_	_
22-12	3243-3246	the	abstract[165]|substance[166]	giv[165]|giv[166]	coref	25-13[0_166]
22-13	3247-3253	enzyme	abstract[165]|substance[166]	giv[165]|giv[166]	_	_
22-14	3254-3263	decreased	_	_	_	_
22-15	3264-3266	by	_	_	_	_
22-16	3267-3268	2	quantity[167]	new[167]	appos	22-19[169_167]
22-17	3269-3271	°C	quantity[167]	new[167]	_	_
22-18	3272-3273	(	_	_	_	_
22-19	3274-3275	T	person|quantity[169]	giv|giv[169]	_	_
22-20	3276-3277	m	quantity[169]	giv[169]	_	_
22-21	3278-3279	,	_	_	_	_
22-22	3280-3283	app	quantity	giv	_	_
22-23	3284-3285	=	_	_	_	_
22-24	3286-3290	63.9	quantity[171]	new[171]	_	_
22-25	3291-3292	±	quantity[171]	new[171]	_	_
22-26	3293-3296	0.2	quantity[171]|quantity[172]	new[171]|new[172]	coref	29-13[0_172]
22-27	3297-3299	°C	quantity[171]|quantity[172]	new[171]|new[172]	_	_
22-28	3300-3301	)	_	_	_	_
22-29	3302-3312	confirming	_	_	_	_
22-30	3313-3314	a	abstract[173]	giv[173]	_	_
22-31	3315-3320	small	abstract[173]	giv[173]	_	_
22-32	3321-3332	stabilizing	abstract[173]	giv[173]	_	_
22-33	3333-3339	effect	abstract[173]	giv[173]	_	_
22-34	3340-3342	of	abstract[173]	giv[173]	_	_
22-35	3343-3352	glutamine	abstract[173]|substance|abstract[175]	giv[173]|giv|giv[175]	coref|coref	27-23[217_175]|32-35
22-36	3353-3365	interactions	abstract[173]|abstract[175]	giv[173]|giv[175]	_	_
22-37	3366-3368	in	abstract[173]|abstract[175]	giv[173]|giv[175]	_	_
22-38	3369-3372	the	abstract[173]|abstract[175]|place[177]	giv[173]|giv[175]|new[177]	coref	29-7[232_177]
22-39	3373-3380	protein	abstract[173]|abstract[175]|substance|place[177]	giv[173]|giv[175]|giv|new[177]	coref	24-17
22-40	3381-3385	core	abstract[173]|abstract[175]|place[177]	giv[173]|giv[175]|new[177]	_	_
22-41	3386-3387	.	_	_	_	_

#Text=Moreover , an interesting shift in substrate specificity from SSG-I to SSG-IV was observed on the variant DmxA Q/N .
23-1	3388-3396	Moreover	_	_	_	_
23-2	3397-3398	,	_	_	_	_
23-3	3399-3401	an	abstract[178]	new[178]	_	_
23-4	3402-3413	interesting	abstract[178]	new[178]	_	_
23-5	3414-3419	shift	abstract[178]	new[178]	_	_
23-6	3420-3422	in	abstract[178]	new[178]	_	_
23-7	3423-3432	substrate	abstract[178]|person|abstract[180]	new[178]|new|giv[180]	coref|coref	24-5|24-4[188_180]
23-8	3433-3444	specificity	abstract[178]|abstract[180]	new[178]|giv[180]	_	_
23-9	3445-3449	from	abstract[178]|abstract[180]	new[178]|giv[180]	_	_
23-10	3450-3455	SSG-I	abstract[178]|abstract[180]|abstract[181]	new[178]|giv[180]|new[181]	_	_
23-11	3456-3458	to	abstract[178]|abstract[180]|abstract[181]	new[178]|giv[180]|new[181]	_	_
23-12	3459-3465	SSG-IV	abstract[178]|abstract[180]|abstract[181]|abstract	new[178]|giv[180]|new[181]|new	_	_
23-13	3466-3469	was	_	_	_	_
23-14	3470-3478	observed	_	_	_	_
23-15	3479-3481	on	_	_	_	_
23-16	3482-3485	the	object[183]|object[184]	new[183]|giv[184]	coref	26-5[0_184]
23-17	3486-3493	variant	object[183]|object[184]	new[183]|giv[184]	_	_
23-18	3494-3498	DmxA	object[184]	giv[184]	_	_
23-19	3499-3502	Q/N	abstract	new	coref	34-9[290_0]
23-20	3503-3504	.	_	_	_	_

#Text=Such changes in the substrate specificity in HLDs are normally only be achieved after a sophisticated protein engineering .
24-1	3505-3509	Such	abstract[186]	new[186]	_	_
24-2	3510-3517	changes	abstract[186]	new[186]	_	_
24-3	3518-3520	in	abstract[186]	new[186]	_	_
24-4	3521-3524	the	abstract[186]|abstract[188]	new[186]|giv[188]	coref	25-15[0_188]
24-5	3525-3534	substrate	abstract[186]|person|abstract[188]	new[186]|giv|giv[188]	coref	25-14
24-6	3535-3546	specificity	abstract[186]|abstract[188]	new[186]|giv[188]	_	_
24-7	3547-3549	in	abstract[186]|abstract[188]	new[186]|giv[188]	_	_
24-8	3550-3554	HLDs	abstract[186]|abstract[188]|substance	new[186]|giv[188]|giv	coref	33-29[284_0]
24-9	3555-3558	are	_	_	_	_
24-10	3559-3567	normally	_	_	_	_
24-11	3568-3572	only	_	_	_	_
24-12	3573-3575	be	_	_	_	_
24-13	3576-3584	achieved	_	_	_	_
24-14	3585-3590	after	_	_	_	_
24-15	3591-3592	a	abstract[191]	new[191]	coref	30-1[238_191]
24-16	3593-3606	sophisticated	abstract[191]	new[191]	_	_
24-17	3607-3614	protein	substance|abstract[191]	giv|new[191]	coref	27-20
24-18	3615-3626	engineering	abstract[191]	new[191]	_	_
24-19	3627-3628	.	_	_	_	_

#Text=In our case , a single mutation was sufficient to shift the enzyme substrate specificity group .
25-1	3629-3631	In	_	_	_	_
25-2	3632-3635	our	person|abstract[193]	giv|giv[193]	ana	31-5
25-3	3636-3640	case	abstract[193]	giv[193]	_	_
25-4	3641-3642	,	_	_	_	_
25-5	3643-3644	a	abstract[194]	new[194]	_	_
25-6	3645-3651	single	abstract[194]	new[194]	_	_
25-7	3652-3660	mutation	abstract[194]	new[194]	_	_
25-8	3661-3664	was	_	_	_	_
25-9	3665-3675	sufficient	_	_	_	_
25-10	3676-3678	to	_	_	_	_
25-11	3679-3684	shift	_	_	_	_
25-12	3685-3688	the	abstract[198]	new[198]	_	_
25-13	3689-3695	enzyme	substance|abstract[198]	giv|new[198]	coref	26-16
25-14	3696-3705	substrate	person|abstract[198]	giv|new[198]	_	_
25-15	3706-3717	specificity	abstract|abstract[198]	giv|new[198]	_	_
25-16	3718-3723	group	abstract[198]	new[198]	_	_
25-17	3724-3725	.	_	_	_	_

#Text=A deeper analysis of DmxA wt structure revealed an unusually small hydrophobic pocket containing the enzyme active site connected with the surrounding solvent by very narrow and closed tunnels .
26-1	3726-3727	A	abstract[199]	new[199]	_	_
26-2	3728-3734	deeper	abstract[199]	new[199]	_	_
26-3	3735-3743	analysis	abstract[199]	new[199]	_	_
26-4	3744-3746	of	abstract[199]	new[199]	_	_
26-5	3747-3751	DmxA	abstract[199]|object|abstract[202]	new[199]|giv|giv[202]	coref|coref	28-18[225_202]|31-19[250_0]
26-6	3752-3754	wt	abstract[199]|abstract|abstract[202]	new[199]|giv|giv[202]	coref	32-7[262_0]
26-7	3755-3764	structure	abstract[199]|abstract[202]	new[199]|giv[202]	_	_
26-8	3765-3773	revealed	_	_	_	_
26-9	3774-3776	an	abstract[203]	new[203]	_	_
26-10	3777-3786	unusually	abstract[203]	new[203]	_	_
26-11	3787-3792	small	abstract[203]	new[203]	_	_
26-12	3793-3804	hydrophobic	abstract[203]	new[203]	_	_
26-13	3805-3811	pocket	abstract[203]	new[203]	_	_
26-14	3812-3822	containing	_	_	_	_
26-15	3823-3826	the	place[205]	new[205]	coref	30-6[241_205]
26-16	3827-3833	enzyme	substance|place[205]	giv|new[205]	coref	29-17
26-17	3834-3840	active	place[205]	new[205]	_	_
26-18	3841-3845	site	place[205]	new[205]	_	_
26-19	3846-3855	connected	_	_	_	_
26-20	3856-3860	with	_	_	_	_
26-21	3861-3864	the	substance[206]	new[206]	coref	30-11[242_206]
26-22	3865-3876	surrounding	substance[206]	new[206]	_	_
26-23	3877-3884	solvent	substance[206]	new[206]	_	_
26-24	3885-3887	by	_	_	_	_
26-25	3888-3892	very	object[207]	new[207]	coref	30-3[239_207]
26-26	3893-3899	narrow	object[207]	new[207]	_	_
26-27	3900-3903	and	object[207]	new[207]	_	_
26-28	3904-3910	closed	object[207]	new[207]	_	_
26-29	3911-3918	tunnels	object[207]	new[207]	_	_
26-30	3919-3920	.	_	_	_	_

#Text=The presence of phenylalanine and methionine as bottleneck residues was not overly surprising since they often provide stabilization of protein structures via hydrophobic interactions .
27-1	3921-3924	The	abstract[208]	new[208]	_	_
27-2	3925-3933	presence	abstract[208]	new[208]	_	_
27-3	3934-3936	of	abstract[208]	new[208]	_	_
27-4	3937-3950	phenylalanine	abstract[208]|plant|abstract[210]	new[208]|new|new[210]	ana	27-15[0_210]
27-5	3951-3954	and	abstract[208]|abstract[210]	new[208]|new[210]	_	_
27-6	3955-3965	methionine	abstract[208]|abstract[210]|substance[211]	new[208]|new[210]|new[211]	_	_
27-7	3966-3968	as	abstract[208]|abstract[210]|substance[211]	new[208]|new[210]|new[211]	_	_
27-8	3969-3979	bottleneck	abstract[208]|abstract[210]|substance[211]|object	new[208]|new[210]|new[211]|new	coref	28-26
27-9	3980-3988	residues	abstract[208]|abstract[210]|substance[211]	new[208]|new[210]|new[211]	_	_
27-10	3989-3992	was	_	_	_	_
27-11	3993-3996	not	_	_	_	_
27-12	3997-4003	overly	_	_	_	_
27-13	4004-4014	surprising	_	_	_	_
27-14	4015-4020	since	_	_	_	_
27-15	4021-4025	they	abstract	giv	_	_
27-16	4026-4031	often	_	_	_	_
27-17	4032-4039	provide	_	_	_	_
27-18	4040-4053	stabilization	abstract[214]	new[214]	_	_
27-19	4054-4056	of	abstract[214]	new[214]	_	_
27-20	4057-4064	protein	abstract[214]|substance|abstract[216]	new[214]|giv|giv[216]	coref	29-8
27-21	4065-4075	structures	abstract[214]|abstract[216]	new[214]|giv[216]	_	_
27-22	4076-4079	via	abstract[214]|abstract[216]	new[214]|giv[216]	_	_
27-23	4080-4091	hydrophobic	abstract[214]|abstract[216]|abstract[217]	new[214]|giv[216]|giv[217]	coref	28-22[0_217]
27-24	4092-4104	interactions	abstract[214]|abstract[216]|abstract[217]	new[214]|giv[216]|giv[217]	_	_
27-25	4105-4106	.	_	_	_	_

#Text=Replacement of bulky residues with alanines in the main tunnel opened the tunnel and suppressed stabilization of the tunnel structure via interactions provided by the bottleneck residues .
28-1	4107-4118	Replacement	event[218]	new[218]	_	_
28-2	4119-4121	of	event[218]	new[218]	_	_
28-3	4122-4127	bulky	event[218]|substance[219]	new[218]|new[219]	coref	28-25[228_219]
28-4	4128-4136	residues	event[218]|substance[219]	new[218]|new[219]	_	_
28-5	4137-4141	with	event[218]|substance[219]	new[218]|new[219]	_	_
28-6	4142-4150	alanines	event[218]|substance[219]|substance[220]	new[218]|new[219]|new[220]	_	_
28-7	4151-4153	in	event[218]|substance[219]|substance[220]	new[218]|new[219]|new[220]	_	_
28-8	4154-4157	the	event[218]|substance[219]|substance[220]|object[221]	new[218]|new[219]|new[220]|new[221]	coref	28-12[222_221]
28-9	4158-4162	main	event[218]|substance[219]|substance[220]|object[221]	new[218]|new[219]|new[220]|new[221]	_	_
28-10	4163-4169	tunnel	event[218]|substance[219]|substance[220]|object[221]	new[218]|new[219]|new[220]|new[221]	_	_
28-11	4170-4176	opened	_	_	_	_
28-12	4177-4180	the	object[222]	giv[222]	coref	28-19[0_222]
28-13	4181-4187	tunnel	object[222]	giv[222]	_	_
28-14	4188-4191	and	_	_	_	_
28-15	4192-4202	suppressed	_	_	_	_
28-16	4203-4216	stabilization	abstract[223]	new[223]	coref	30-23[244_223]
28-17	4217-4219	of	abstract[223]	new[223]	_	_
28-18	4220-4223	the	abstract[223]|abstract[225]	new[223]|giv[225]	_	_
28-19	4224-4230	tunnel	abstract[223]|object|abstract[225]	new[223]|giv|giv[225]	ana	29-1
28-20	4231-4240	structure	abstract[223]|abstract[225]	new[223]|giv[225]	_	_
28-21	4241-4244	via	abstract[223]|abstract[225]	new[223]|giv[225]	_	_
28-22	4245-4257	interactions	abstract[223]|abstract[225]|abstract	new[223]|giv[225]|giv	coref	31-27[253_0]
28-23	4258-4266	provided	_	_	_	_
28-24	4267-4269	by	_	_	_	_
28-25	4270-4273	the	substance[228]	giv[228]	_	_
28-26	4274-4284	bottleneck	object|substance[228]	giv|giv[228]	_	_
28-27	4285-4293	residues	substance[228]	giv[228]	_	_
28-28	4294-4295	.	_	_	_	_

#Text=This led to the destabilization of the protein core represented by 9 °C decrease of the enzyme apparent melting temperature .
29-1	4296-4300	This	object	giv	coref	32-41[273_0]
29-2	4301-4304	led	_	_	_	_
29-3	4305-4307	to	_	_	_	_
29-4	4308-4311	the	event[230]	new[230]	_	_
29-5	4312-4327	destabilization	event[230]	new[230]	_	_
29-6	4328-4330	of	event[230]	new[230]	_	_
29-7	4331-4334	the	event[230]|substance[232]	new[230]|giv[232]	_	_
29-8	4335-4342	protein	event[230]|substance|substance[232]	new[230]|giv|giv[232]	_	_
29-9	4343-4347	core	event[230]|substance[232]	new[230]|giv[232]	_	_
29-10	4348-4359	represented	_	_	_	_
29-11	4360-4362	by	_	_	_	_
29-12	4363-4364	9	event[234]	new[234]	_	_
29-13	4365-4367	°C	quantity|event[234]	giv|new[234]	_	_
29-14	4368-4376	decrease	event[234]	new[234]	_	_
29-15	4377-4379	of	event[234]	new[234]	_	_
29-16	4380-4383	the	event[234]|abstract[237]	new[234]|giv[237]	coref	33-22[283_237]
29-17	4384-4390	enzyme	event[234]|substance|abstract[237]	new[234]|giv|giv[237]	coref	30-7
29-18	4391-4399	apparent	event[234]|abstract[237]	new[234]|giv[237]	_	_
29-19	4400-4407	melting	event[234]|object|abstract[237]	new[234]|giv|giv[237]	coref	33-23
29-20	4408-4419	temperature	event[234]|abstract[237]	new[234]|giv[237]	_	_
29-21	4420-4421	.	_	_	_	_

#Text=Engineering of the tunnels connecting buried enzyme active site with the surrounding solvent has previously been described as a powerful strategy for enzyme stabilization .
30-1	4422-4433	Engineering	abstract[238]	giv[238]	_	_
30-2	4434-4436	of	abstract[238]	giv[238]	_	_
30-3	4437-4440	the	abstract[238]|object[239]	giv[238]|giv[239]	coref	31-8[247_239]
30-4	4441-4448	tunnels	abstract[238]|object[239]	giv[238]|giv[239]	_	_
30-5	4449-4459	connecting	_	_	_	_
30-6	4460-4466	buried	place[241]	giv[241]	_	_
30-7	4467-4473	enzyme	substance|place[241]	giv|giv[241]	coref	30-23
30-8	4474-4480	active	place[241]	giv[241]	_	_
30-9	4481-4485	site	place[241]	giv[241]	_	_
30-10	4486-4490	with	place[241]	giv[241]	_	_
30-11	4491-4494	the	place[241]|substance[242]	giv[241]|giv[242]	_	_
30-12	4495-4506	surrounding	place[241]|substance[242]	giv[241]|giv[242]	_	_
30-13	4507-4514	solvent	place[241]|substance[242]	giv[241]|giv[242]	_	_
30-14	4515-4518	has	_	_	_	_
30-15	4519-4529	previously	_	_	_	_
30-16	4530-4534	been	_	_	_	_
30-17	4535-4544	described	_	_	_	_
30-18	4545-4547	as	_	_	_	_
30-19	4548-4549	a	_	_	_	_
30-20	4550-4558	powerful	_	_	_	_
30-21	4559-4567	strategy	_	_	_	_
30-22	4568-4571	for	_	_	_	_
30-23	4572-4578	enzyme	substance|abstract[244]	giv|giv[244]	coref|coref	31-43[257_0]|32-29[268_244]
30-24	4579-4592	stabilization	abstract[244]	giv[244]	_	_
30-25	4593-4594	.	_	_	_	_

#Text=In this study , we proved that narrow tunnels play a crucial role in the paradoxical stability of DmxA due to multiple van der Waals and hydrophobic interactions , although they are not the only factor responsible for the unique properties of the enzyme .
31-1	4595-4597	In	_	_	_	_
31-2	4598-4602	this	abstract[245]	new[245]	_	_
31-3	4603-4608	study	abstract[245]	new[245]	_	_
31-4	4609-4610	,	_	_	_	_
31-5	4611-4613	we	person	giv	ana	32-14
31-6	4614-4620	proved	_	_	_	_
31-7	4621-4625	that	_	_	_	_
31-8	4626-4632	narrow	object[247]	giv[247]	_	_
31-9	4633-4640	tunnels	object[247]	giv[247]	_	_
31-10	4641-4645	play	_	_	_	_
31-11	4646-4647	a	abstract[248]	new[248]	_	_
31-12	4648-4655	crucial	abstract[248]	new[248]	_	_
31-13	4656-4660	role	abstract[248]	new[248]	_	_
31-14	4661-4663	in	_	_	_	_
31-15	4664-4667	the	abstract[249]	new[249]	_	_
31-16	4668-4679	paradoxical	abstract[249]	new[249]	_	_
31-17	4680-4689	stability	abstract[249]	new[249]	_	_
31-18	4690-4692	of	abstract[249]	new[249]	_	_
31-19	4693-4697	DmxA	abstract[249]|object[250]	new[249]|giv[250]	coref	32-11[0_250]
31-20	4698-4701	due	abstract[249]|object[250]	new[249]|giv[250]	_	_
31-21	4702-4704	to	_	_	_	_
31-22	4705-4713	multiple	object[251]	new[251]	_	_
31-23	4714-4717	van	object[251]	new[251]	_	_
31-24	4718-4721	der	object[251]|person[252]	new[251]|new[252]	_	_
31-25	4722-4727	Waals	object[251]|person[252]	new[251]|new[252]	_	_
31-26	4728-4731	and	_	_	_	_
31-27	4732-4743	hydrophobic	abstract[253]	giv[253]	ana	31-31[0_253]
31-28	4744-4756	interactions	abstract[253]	giv[253]	_	_
31-29	4757-4758	,	_	_	_	_
31-30	4759-4767	although	_	_	_	_
31-31	4768-4772	they	abstract	giv	_	_
31-32	4773-4776	are	_	_	_	_
31-33	4777-4780	not	_	_	_	_
31-34	4781-4784	the	abstract[255]	new[255]	_	_
31-35	4785-4789	only	abstract[255]	new[255]	_	_
31-36	4790-4796	factor	abstract[255]	new[255]	_	_
31-37	4797-4808	responsible	abstract[255]	new[255]	_	_
31-38	4809-4812	for	_	_	_	_
31-39	4813-4816	the	abstract[256]	new[256]	_	_
31-40	4817-4823	unique	abstract[256]	new[256]	_	_
31-41	4824-4834	properties	abstract[256]	new[256]	_	_
31-42	4835-4837	of	abstract[256]	new[256]	_	_
31-43	4838-4841	the	abstract[256]|abstract[257]	new[256]|giv[257]	coref	32-20[265_257]
31-44	4842-4848	enzyme	abstract[256]|abstract[257]	new[256]|giv[257]	_	_
31-45	4849-4850	.	_	_	_	_

#Text=To decipher the high stability of the new haloalkane dehalogenase DmxA wt , we investigated three unique features of the enzyme , corresponding to three possible sources of its stabilization . Both replacements of glutamine with asparagine and opening of the main tunnel brought desired outcomes in terms of decreased stability and improved activity .
32-1	4851-4853	To	_	_	_	_
32-2	4854-4862	decipher	_	_	_	_
32-3	4863-4866	the	abstract[258]	new[258]	_	_
32-4	4867-4871	high	abstract[258]	new[258]	_	_
32-5	4872-4881	stability	abstract[258]	new[258]	_	_
32-6	4882-4884	of	abstract[258]	new[258]	_	_
32-7	4885-4888	the	abstract[258]|abstract[262]	new[258]|giv[262]	ana	32-29[0_262]
32-8	4889-4892	new	abstract[258]|abstract[262]	new[258]|giv[262]	_	_
32-9	4893-4903	haloalkane	abstract[258]|object|abstract[262]	new[258]|new|giv[262]	_	_
32-10	4904-4916	dehalogenase	abstract[258]|abstract|abstract[262]	new[258]|new|giv[262]	_	_
32-11	4917-4921	DmxA	abstract[258]|abstract|abstract[262]	new[258]|giv|giv[262]	coref	34-9
32-12	4922-4924	wt	abstract[258]|abstract[262]	new[258]|giv[262]	_	_
32-13	4925-4926	,	_	_	_	_
32-14	4927-4929	we	person	giv	ana	33-9
32-15	4930-4942	investigated	_	_	_	_
32-16	4943-4948	three	abstract[264]	new[264]	_	_
32-17	4949-4955	unique	abstract[264]	new[264]	_	_
32-18	4956-4964	features	abstract[264]	new[264]	_	_
32-19	4965-4967	of	abstract[264]	new[264]	_	_
32-20	4968-4971	the	abstract[264]|substance[265]	new[264]|giv[265]	coref	33-13[280_265]
32-21	4972-4978	enzyme	abstract[264]|substance[265]	new[264]|giv[265]	_	_
32-22	4979-4980	,	_	_	_	_
32-23	4981-4994	corresponding	_	_	_	_
32-24	4995-4997	to	_	_	_	_
32-25	4998-5003	three	abstract[266]	new[266]	_	_
32-26	5004-5012	possible	abstract[266]	new[266]	_	_
32-27	5013-5020	sources	abstract[266]	new[266]	_	_
32-28	5021-5023	of	abstract[266]	new[266]	_	_
32-29	5024-5027	its	abstract[266]|abstract|abstract[268]	new[266]|giv|giv[268]	_	_
32-30	5028-5041	stabilization	abstract[266]|abstract[268]	new[266]|giv[268]	_	_
32-31	5042-5043	.	_	_	_	_
32-32	5044-5048	Both	event[269]	new[269]	_	_
32-33	5049-5061	replacements	event[269]	new[269]	_	_
32-34	5062-5064	of	event[269]	new[269]	_	_
32-35	5065-5074	glutamine	event[269]|substance	new[269]|giv	_	_
32-36	5075-5079	with	event[269]	new[269]	_	_
32-37	5080-5090	asparagine	event[269]|substance	new[269]|giv	_	_
32-38	5091-5094	and	event[269]	new[269]	_	_
32-39	5095-5102	opening	event[269]|event[272]	new[269]|new[272]	_	_
32-40	5103-5105	of	event[269]|event[272]	new[269]|new[272]	_	_
32-41	5106-5109	the	event[269]|event[272]|object[273]	new[269]|new[272]|giv[273]	_	_
32-42	5110-5114	main	event[269]|event[272]|object[273]	new[269]|new[272]|giv[273]	_	_
32-43	5115-5121	tunnel	event[269]|event[272]|object[273]	new[269]|new[272]|giv[273]	_	_
32-44	5122-5129	brought	_	_	_	_
32-45	5130-5137	desired	abstract[274]	new[274]	_	_
32-46	5138-5146	outcomes	abstract[274]	new[274]	_	_
32-47	5147-5149	in	abstract[274]	new[274]	_	_
32-48	5150-5155	terms	abstract[274]	new[274]	_	_
32-49	5156-5158	of	abstract[274]	new[274]	_	_
32-50	5159-5168	decreased	abstract[274]|abstract[275]|abstract[276]	new[274]|new[275]|giv[276]	_	_
32-51	5169-5178	stability	abstract[274]|abstract[275]|abstract[276]	new[274]|new[275]|giv[276]	_	_
32-52	5179-5182	and	abstract[274]|abstract[276]	new[274]|giv[276]	_	_
32-53	5183-5191	improved	abstract[274]|abstract[276]|abstract[277]	new[274]|giv[276]|giv[277]	_	_
32-54	5192-5200	activity	abstract[274]|abstract[276]|abstract[277]	new[274]|giv[276]|giv[277]	_	_
32-55	5201-5202	.	_	_	_	_

#Text=More importantly , introducing only two mutations , we managed to turn the thermostable enzyme into a mesophilic-like counterpart , with a melting temperature comparable to that of other related HLDs and a significantly improved catalytic performance .
33-1	5203-5207	More	_	_	_	_
33-2	5208-5219	importantly	_	_	_	_
33-3	5220-5221	,	_	_	_	_
33-4	5222-5233	introducing	_	_	_	_
33-5	5234-5238	only	abstract[278]	new[278]	coref	34-7[288_278]
33-6	5239-5242	two	abstract[278]	new[278]	_	_
33-7	5243-5252	mutations	abstract[278]	new[278]	_	_
33-8	5253-5254	,	_	_	_	_
33-9	5255-5257	we	person	giv	ana	34-2
33-10	5258-5265	managed	_	_	_	_
33-11	5266-5268	to	_	_	_	_
33-12	5269-5273	turn	_	_	_	_
33-13	5274-5277	the	substance[280]	giv[280]	coref	34-16[294_280]
33-14	5278-5290	thermostable	substance[280]	giv[280]	_	_
33-15	5291-5297	enzyme	substance[280]	giv[280]	_	_
33-16	5298-5302	into	_	_	_	_
33-17	5303-5304	a	abstract[281]	new[281]	_	_
33-18	5305-5320	mesophilic-like	abstract[281]	new[281]	_	_
33-19	5321-5332	counterpart	abstract[281]	new[281]	_	_
33-20	5333-5334	,	_	_	_	_
33-21	5335-5339	with	_	_	_	_
33-22	5340-5341	a	abstract[283]	giv[283]	_	_
33-23	5342-5349	melting	object|abstract[283]	giv|giv[283]	_	_
33-24	5350-5361	temperature	abstract[283]	giv[283]	_	_
33-25	5362-5372	comparable	abstract[283]	giv[283]	_	_
33-26	5373-5375	to	_	_	_	_
33-27	5376-5380	that	_	_	_	_
33-28	5381-5383	of	_	_	_	_
33-29	5384-5389	other	substance[284]	giv[284]	_	_
33-30	5390-5397	related	substance[284]	giv[284]	_	_
33-31	5398-5402	HLDs	substance[284]	giv[284]	_	_
33-32	5403-5406	and	_	_	_	_
33-33	5407-5408	a	abstract[285]	new[285]	_	_
33-34	5409-5422	significantly	abstract[285]	new[285]	_	_
33-35	5423-5431	improved	abstract[285]	new[285]	_	_
33-36	5432-5441	catalytic	abstract[285]	new[285]	_	_
33-37	5442-5453	performance	abstract[285]	new[285]	_	_
33-38	5454-5455	.	_	_	_	_

#Text=If we combined the effects of mutations in DmxA Q/N and DmxA MF/AA variants , the consequent enzyme would result in a highly active catalyst .
34-1	5456-5458	If	_	_	_	_
34-2	5459-5461	we	person	giv	_	_
34-3	5462-5470	combined	_	_	_	_
34-4	5471-5474	the	abstract[287]	new[287]	_	_
34-5	5475-5482	effects	abstract[287]	new[287]	_	_
34-6	5483-5485	of	abstract[287]	new[287]	_	_
34-7	5486-5495	mutations	abstract[287]|abstract[288]	new[287]|giv[288]	_	_
34-8	5496-5498	in	abstract[287]|abstract[288]	new[287]|giv[288]	_	_
34-9	5499-5503	DmxA	abstract[287]|abstract[288]|abstract|abstract[290]	new[287]|giv[288]|giv|giv[290]	coref	34-12
34-10	5504-5507	Q/N	abstract[287]|abstract[288]|abstract[290]	new[287]|giv[288]|giv[290]	_	_
34-11	5508-5511	and	abstract[287]|abstract[288]	new[287]|giv[288]	_	_
34-12	5512-5516	DmxA	abstract[287]|abstract[288]|abstract|abstract[293]	new[287]|giv[288]|giv|new[293]	_	_
34-13	5517-5522	MF/AA	abstract[287]|abstract[288]|abstract|abstract[293]	new[287]|giv[288]|new|new[293]	_	_
34-14	5523-5531	variants	abstract[287]|abstract[288]|abstract[293]	new[287]|giv[288]|new[293]	_	_
34-15	5532-5533	,	_	_	_	_
34-16	5534-5537	the	substance[294]	giv[294]	_	_
34-17	5538-5548	consequent	substance[294]	giv[294]	_	_
34-18	5549-5555	enzyme	substance[294]	giv[294]	_	_
34-19	5556-5561	would	_	_	_	_
34-20	5562-5568	result	_	_	_	_
34-21	5569-5571	in	_	_	_	_
34-22	5572-5573	a	object[295]	new[295]	_	_
34-23	5574-5580	highly	object[295]	new[295]	_	_
34-24	5581-5587	active	object[295]	new[295]	_	_
34-25	5588-5596	catalyst	object[295]	new[295]	_	_
34-26	5597-5598	.	_	_	_	_
